Notice détaillée
Titre
UPDANGELO
Formal Name (French)
Unité provisoire pour le Prof. D'Angelo
Formal Name (English)
Prof. D'Angelo Group
Lab Manager
D'Angelo, Giovanni
Group ID
U13605
Auteurs affilié
Asaro, Antonino
Asirim, Ece Zeynep
Barahtjan, Pavel
Capolupo, Laura
Crotta Asis, Agostina
D'Angelo, Giovanni
Droin, Colas Noé
Gehin, Charlotte
Gorsek, Nika
Haj Abdullah Alieh, Leila
Kaysudu, Irmak
Lin, Jiayan
Loomba, Jaipreet Singh
Maillat, Jean Andrea
Marchegiano, Sonia
Nasrallah, Anita
Paz Montoya, Jonathan
Schede, Halima Hannah Emilie
Talotta, Francesco
Vocat, Anthony
Asirim, Ece Zeynep
Barahtjan, Pavel
Capolupo, Laura
Crotta Asis, Agostina
D'Angelo, Giovanni
Droin, Colas Noé
Gehin, Charlotte
Gorsek, Nika
Haj Abdullah Alieh, Leila
Kaysudu, Irmak
Lin, Jiayan
Loomba, Jaipreet Singh
Maillat, Jean Andrea
Marchegiano, Sonia
Nasrallah, Anita
Paz Montoya, Jonathan
Schede, Halima Hannah Emilie
Talotta, Francesco
Vocat, Anthony
Institut
IBI-SV
Faculté
SV
Lien extérieur
https://bioengineering.epfl.ch/welcome
Publications
CERT1 mutations perturb human development by disrupting sphingolipid homeostasis
Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tube[...]
Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients
Glycosphingolipid Metabolic Reprogramming Drives Neural Differentiation
Glycosphingolipid metabolism in cell fate specification
Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3
Single-cell lipidomics reveals a role for cell-to-cell sphingolipid heterogeneity in fibroblast activation
Synthesis and In Vitro Biological Evaluation of Quinolinyl Pyrimidines Targeting Type II NADH-Dehydrogenase (NDH-2)
Synthesis of New Indole and Adamantane Amido Derivatives with Pharmacological Interest
Type 2 diabetes disrupts circadian orchestration of lipid metabolism and membrane fluidity in human pancreatic islets
Voir toutes les publications (48)
Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tube[...]
Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients
Glycosphingolipid Metabolic Reprogramming Drives Neural Differentiation
Glycosphingolipid metabolism in cell fate specification
Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3
Single-cell lipidomics reveals a role for cell-to-cell sphingolipid heterogeneity in fibroblast activation
Synthesis and In Vitro Biological Evaluation of Quinolinyl Pyrimidines Targeting Type II NADH-Dehydrogenase (NDH-2)
Synthesis of New Indole and Adamantane Amido Derivatives with Pharmacological Interest
Type 2 diabetes disrupts circadian orchestration of lipid metabolism and membrane fluidity in human pancreatic islets
Voir toutes les publications (48)
Le document apparaît dans
Authorities > Lab